Abstract
Hematopoietic stem cell transplant (HSCT) is a curative treatment for many diseases especially inherited genetic diseases such as thalassemia, inherited bone marrow failure syndromes, primary immunodeficiencies, Gaucher disease, Hunter syndrome, or other mucopolysaccharidoses. The two main elements of HSCT are the conditioning regimen and an available donor. The conditioning regimen included combined chemotherapy, monoclonal antibody, or radiation, while the available donor might be HLA-identical or HLA-mismatched.
| Original language | English |
|---|---|
| Title of host publication | Recent Advances in Molecular and Translational Medicine |
| Subtitle of host publication | Updates in Precision Medicine |
| Publisher | Bentham Science Publishers |
| Pages | 225-234 |
| Number of pages | 10 |
| ISBN (Electronic) | 9789815036756 |
| ISBN (Print) | 9789815036763 |
| DOIs | |
| Publication status | Published - 1 Jan 2021 |
Keywords
- Conditioning Regimen
- Fanconi Anemia
- Hematopoietic Stem Cell Transplantation
- Human Leukocyte Antigen
- Severe Combined Immunodeficiency Syndrome
- Thalassemia
Fingerprint
Dive into the research topics of 'Hematopoietic Stem Cell Transplant in Inherited Genetic Diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver